206 related articles for article (PubMed ID: 21199876)
1. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins.
Nishiya T; Matsumoto K; Maekawa S; Kajita E; Horinouchi T; Fujimuro M; Ogasawara K; Uehara T; Miwa S
J Biol Chem; 2011 Mar; 286(11):9009-19. PubMed ID: 21199876
[TBL] [Abstract][Full Text] [Related]
2. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.
Kuang Z; Lewis RS; Curtis JM; Zhan Y; Saunders BM; Babon JJ; Kolesnik TB; Low A; Masters SL; Willson TA; Kedzierski L; Yao S; Handman E; Norton RS; Nicholson SE
J Cell Biol; 2010 Jul; 190(1):129-41. PubMed ID: 20603330
[TBL] [Abstract][Full Text] [Related]
3. The ECS(SPSB) E3 ubiquitin ligase is the master regulator of the lifetime of inducible nitric-oxide synthase.
Matsumoto K; Nishiya T; Maekawa S; Horinouchi T; Ogasawara K; Uehara T; Miwa S
Biochem Biophys Res Commun; 2011 May; 409(1):46-51. PubMed ID: 21549100
[TBL] [Abstract][Full Text] [Related]
4. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction.
Lewis RS; Kolesnik TB; Kuang Z; D'Cruz AA; Blewitt ME; Masters SL; Low A; Willson T; Norton RS; Nicholson SE
J Immunol; 2011 Oct; 187(7):3798-805. PubMed ID: 21876038
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase.
Li K; You T; Zhao P; Luo Y; Zhang D; Wei H; Wang Y; Yang J; Guan X; Kuang Z
Nitric Oxide; 2021 Sep; 113-114():1-6. PubMed ID: 33862200
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4.
Filippakopoulos P; Low A; Sharpe TD; Uppenberg J; Yao S; Kuang Z; Savitsky P; Lewis RS; Nicholson SE; Norton RS; Bullock AN
J Mol Biol; 2010 Aug; 401(3):389-402. PubMed ID: 20561531
[TBL] [Abstract][Full Text] [Related]
7. A Cyclic Peptide Inhibitor of the iNOS-SPSB Protein-Protein Interaction as a Potential Anti-Infective Agent.
Sadek MM; Barlow N; Leung EWW; Williams-Noonan BJ; Yap BK; Shariff FM; Caradoc-Davies TT; Nicholson SE; Chalmers DK; Thompson PE; Law RHP; Norton RS
ACS Chem Biol; 2018 Oct; 13(10):2930-2938. PubMed ID: 30226743
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the SPRY domain of human SPSB2 in the apo state.
Luo Y; Li K; Yang J; Zhang D; Zhou Y; Kuang Z
Acta Crystallogr F Struct Biol Commun; 2019 Jun; 75(Pt 6):412-418. PubMed ID: 31204687
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.
Harjani JR; Yap BK; Leung EW; Lucke A; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Norton RS; Baell JB
J Med Chem; 2016 Jun; 59(12):5799-809. PubMed ID: 27214043
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
Wang T; Luo S; Qin H; Xia Y
Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
[TBL] [Abstract][Full Text] [Related]
11. Anti-Infective Peptides to Enhance the Host Innate Response: Design, Development and Delivery.
Norton RS
Protein Pept Lett; 2018; 25(12):1101-1107. PubMed ID: 30381058
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction.
You T; Wang Y; Li K; Zhang D; Wei H; Luo Y; Li H; Lu Y; Su X; Kuang Z
Biochem Biophys Res Commun; 2017 Jul; 489(3):346-352. PubMed ID: 28549582
[TBL] [Abstract][Full Text] [Related]
13. Enhanced nitric oxide production by macrophages treated with a cell-penetrating peptide conjugate.
Rahman A; Matthews MA; Nowell CJ; Chalmers DK; Thompson PE; Nicholson SE; Barlow N; Norton RS
Bioorg Chem; 2022 Jun; 123():105763. PubMed ID: 35366581
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins as negative regulators against lipopolysaccharide, lipoteichoic acid, and peptidoglycan-induced inducible nitric oxide synthase/nitric oxide production through reactive oxygen species-dependent heme oxygenase 1 expression in macrophages.
Chien CC; Shen SC; Yang LY; Chen YC
Shock; 2012 Nov; 38(5):549-58. PubMed ID: 23042187
[TBL] [Abstract][Full Text] [Related]
15. SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation.
Wang M; Wang Y; Liu Y; Wang H; Xin X; Li J; Hao Y; Han L; Yu F; Zheng C; Shen C
PLoS One; 2019; 14(7):e0219989. PubMed ID: 31344133
[TBL] [Abstract][Full Text] [Related]
16. The E3 Ligases Spsb1 and Spsb4 Regulate RevErbα Degradation and Circadian Period.
Mekbib T; Suen TC; Rollins-Hairston A; DeBruyne JP
J Biol Rhythms; 2019 Dec; 34(6):610-621. PubMed ID: 31607207
[TBL] [Abstract][Full Text] [Related]
17. Redox-stable cyclic peptide inhibitors of the SPSB2-iNOS interaction.
Yap BK; Harjani JR; Leung EW; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Baell JB; Norton RS
FEBS Lett; 2016 Mar; 590(6):696-704. PubMed ID: 26921848
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
19. Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages.
Kang YS; Kang YG; Park HJ; Wee HJ; Jang HO; Bae MK; Bae SK
J Pineal Res; 2013 Oct; 55(3):294-303. PubMed ID: 23869429
[TBL] [Abstract][Full Text] [Related]
20. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
